Strategy For the Implementation of The Modern Digital Track-And-Trace System in Pharmaceutical Circulation

This article examines the scientific-theoretical and practical aspects of implementing a modern digital Track & Trace system in the circulation of pharmaceutical products. This study was conducted at public legal entity “Analytical Expertise Center” of the Ministry of Health of Azerbaijan Republic, and aimed to evaluate the implementation of digital tracking mechanisms in the circulation of pharmaceutical products. Tracking models developed within the regulatory frameworks of the European Union’s Falsified Medicines Directive (FMD) and the United States Drug Supply Chain Security Act (DSCSA) are analyzed, and the possibilities for their adaptation to national conditions are assessed. Based on the conducted analysis, a strategic model involving phased implementation is proposed for the national context. The model identifies the marking of pharmaceutical products with unique identification codes, real-time data exchange across the supply chain, and the execution of state regulatory control through a unified digital platform as key mechanisms.The proposed strategy contributes to preventing the circulation of falsified and substandard pharmaceutical products, optimizing regulatory control processes, and enhancing the overall safety of pharmaceutical circulation